Close Monitoring Recommended Despite Reduced Risk of COVID-19 Mortality in CLL - OncLive
5/29/2022 12:00:00 AM2 years 11 months ago
by Caroline Seymour
by Caroline Seymour
Although lower fatality rates were reported during the omicron wave of the COVID-19 pandemic in patients with chronic lymphocytic leukemia, close monitoring and preemptive antiviral therapy is still recommended following a positive SARS-CoV-2 test, particular…
Although lower fatality rates were reported during the omicron wave of the COVID-19 pandemic in patients with chronic lymphocytic leukemia (CLL), close monitoring and preemptive antiviral therapy is … [+5595 chars]
full article...